Compounds > ly 300164
Page last updated: 2024-09-05

ly 300164 and topiramate

ly 300164 has been researched along with topiramate in 1 studies

Compound Research Comparison

Studies
(ly 300164)		Trials
(ly 300164)		Recent Studies (post-2010)
(ly 300164)		Studies
(topiramate)		Trials
(topiramate)		Recent Studies (post-2010) (topiramate)
737123,1975571,329

Protein Interaction Comparison

ProteinTaxonomyly 300164 (IC50)topiramate (IC50)
Carbonic anhydrase 1Homo sapiens (human)0.25
Carbonic anhydrase 2Homo sapiens (human)0.8683
Carbonic anhydrase 2Rattus norvegicus (Norway rat)1.4
Carbonic anhydrase 4Bos taurus (cattle)0.054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aujla, PK; Fishman, R; Jensen, FE; Rakhade, SN; Sucher, NJ; Zhou, C1

Other Studies

1 other study(ies) available for ly 300164 and topiramate

ArticleYear
Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Aug-06, Volume: 28, Issue:32

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Disease Susceptibility; Enzyme Activation; Epilepsy; Excitatory Postsynaptic Potentials; Fructose; Hypoxia; Male; Phosphorylation; Protein Kinase C; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Topiramate

2008